Notes - Consolidated Statement Of Income

Daito Chemix Corporation - Filing #7251809

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
Notes - Consolidated statement of income
Notes - Consolidated statement of income
Notes regarding amount of revenue from contracts with customers

※1 顧客との契約から生じる収益

当社グループの売上高は、すべて顧客との契約から生じる収益であり、連結財務諸表「注記事項(収益認識関係)1.顧客との契約から生じる収益を分解した情報」に記載しております。

Notes regarding write-downs of inventories
Write-downs of inventories
-25,000,000 JPY
98,000,000 JPY
Major components of selling, general and administrative expenses
Research and development expenses included in general and administrative expenses and manufacturing costs for period
Research and development expenses included in general and administrative expenses and manufacturing costs for period
1,131,000,000 JPY
1,126,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.